394800 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
3billion, Inc. engages in the provision of genetic testing and analyzing services to rare disease patients. The firm's products include 3B-Genome, 3B-Exome, 3B-Variant, and 3B-Interpreter. Its services include sequencing, artificial intelligence (AI) genetic mutation pathogenicity reading, full-length exome and genome analysis gene region, and proband target scope. The company was founded by Chang-Won Keum on October 10, 2016 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
394800 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company